Colonics
 
About Me

Colonics resources

Recent Posts
Menu
Calendar
«  October 2014  »
MonTueWedThuFriSatSun
 12345
6789101112
13141516171819
20212223242526
2728293031 

Friends
    Links


    Entry 1 of 3156
    Last Page | Next Page
    3/17/2010 - Abraxis BioScience's Phase 3 trial comparing ABRAXANE with Taxol injection meets primary endpoint
    Posted in Medical News

    Abraxis BioScience, Inc. today announced that its randomized registrational Phase 3 clinical trial comparing ABRAXANE® (protein-bound paclitaxel) with Taxol® (paclitaxel) injection, both in unity with carboplatin, met the study’s primary endpoint by demonstrating that ABRAXANE showed a meaning upgrade




    if (lexico_globals.googleafc.ads.content.length)
    {
    document.write(lexico_globals.googleafc.ads.contenttop);
    document.write(lexico_globals.googleafc.ads.sponsoredlinks);
    document.write(lexico_globals.googleafc.ads.content[2]);
    document.write("" in overall third edition by the editors of the stars and stripes heritage� dictionary. copyright � 2003 rate as compared to Taxol, in the first-line regimen of career with farthest non-small cell lung cancer (NSCLC), as assessed by autonomy radiologist review.

    More: - Brought to my attention by

    Share |

    :: Send to a Friend!

    Share and enjoy
    • Digg
    • del.icio.us
    • DZone
    • Netvouz
    • NewsVine
    • Reddit
    • Slashdot
    • StumbleUpon
    • Technorati
    • YahooMyWeb
     
    portfolio